ALS is pleased to confirm the acquisition of Mikrolab Group in Sweden on 3rd October 2017. The group consist of 3 entities; Mikrolab Stockholm AB, MKL Diagnostics AB and Toxicon AB. The newly acquired laboratories provides Pharmaceutical, Environmental and Food testing to a broad range of clients.

Commenting on the acquisition, Andreas Jonsson, ALS Europe General Manager:

This exciting acquisition represents a step-change for the ALS Pharmaceutical business, providing a great opportunity by increasing the depth and breadth of our proposition to clients. In addition the acquisition brings new capabilities, in particular in regards to toxicology testing, further broadening our environmental testing portfolio.

The senior management team of Mikrolab Group are remaining with ALS and will take on senior operational and business development roles in the company.